Producer: Clayton Taylor;
[AI-Generated Summary] This investigative news report by WISH-TV details how the rapidly growing home infusion (home IV) therapy industry is driving up healthcare costs through questionable financial referral practices and inflated billing. Reporter Mike Ahern reveals that home infusion providers frequently pay sizable referral fees or "clinical management fees" to doctors and hospitals—such as a lucrative contract between IU Home Care and Critical Care America—in exchange for steering unsuspecting patients to their services, effectively operating as legal kickbacks outside of Medicare and Medicaid. These financial arrangements prompt providers to heavily mark up the prices of home IV medications and supplies, which insurance companies often pay without scrutiny and ultimately pass on to consumers. To protect themselves from price gouging and financial conflicts of interest, experts advise patients to demand itemized bills, compare provider prices, and directly question their doctors about any financial ties to recommended home health care companies.
This AI-generated summary (via Gemini AI and Adobe Premiere Pro) is for discovery purposes only. Please consult the original recording for historical accuracy.